Sabrina C. Desbordes is director of the Stem Cell Platform at ISAR Bioscience. She studied Biology and Chemistry in Avignon and Montpellier in France and obtained her PhD in Genetics from the University of Cambridge, UK. After her postdoctoral training at the Memorial Sloan-Kettering Cancer Center in NY, USA with Dr. med. Lorenz Studer, and at the Center for Genomic Regulation in Barcelona, Spain, she started her own research group at the Helmholtz Zentrum München in 2012. Soon after, she created the Stem Cell-based Assay Development (SCADEV) platform, where she headed collaborative projects with academic and industrial partners. She joined ISAR Bioscience in 2019.
Dr. Desbordes received several awards and funding, notably from the British Society of Developmental Biology, the Cambridge European Trust, the Spanish State Research Agency, the New York Academy of Sciences as well as the Deutsche Diabetes Gesellschaft and published in high impact journals. She is a pioneer in the adaptation of human pluripotent stem cells and derivatives to high-throughput screening assays for drug discovery and develops innovative human stem cell products and strategies supporting various stem cell differentiations, including the generation of organoids.